3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
7
Other solid neoplasm
7
Sarcoma
2
Gastrointestinal
2
Head & Neck
1
Gynecologic
1
Endocrine
1
CNS
1
Conditions
Ovarian Neoplasms
51
Endometrial Neoplasms
21
Fallopian Tube Neoplasms
17
Sarcoma
9
Peritoneal Neoplasms
9
Neoplasm Metastasis
7
Neoplasms
6
Liposarcoma
6
Leiomyosarcoma
5
Hemangiosarcoma
5
Fibrosarcoma
5
Carcinoma, Ovarian Epithelial
5
Uterine Neoplasms
4
Stomach Neoplasms
4
Sarcoma, Synovial
4
Recurrence
4
Neurofibrosarcoma
4
Malignant mesenchymal tumor
4
Histiocytoma, Malignant Fibrous
4
Desmoplastic Small Round Cell Tumor
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma, Endometrial Stromal
3
Rhabdomyosarcoma
3
Hemangiopericytoma, Malignant
3
Breast Neoplasms
3
Appendiceal Neoplasms
3
Sarcoma, Alveolar Soft Part
2
Pheochromocytoma
2
Interventions
pembrolizumab
2
fludarabine
2
SS1(dsFv)PE38
2
Platinum
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cyclophosphamide
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
enzalutamide
1
entinostat
1
X-Rays
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Polymerase Chain Reaction
1
Paclitaxel
1
Nivolumab
1
Microarray Analysis
1
Megestrol Acetate
1
Magnetic Resonance Spectroscopy
1
Levoleucovorin
1
Leucovorin
1
Ipilimumab
1
Interleukin-2
1
In Situ Hybridization, Fluorescence
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Doxorubicin
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled